ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$129
-100.0%
29,778
-70.7%
0.00%
-100.0%
Q1 2022$1,151,000
-72.3%
101,763
-61.5%
0.00%
-80.0%
Q4 2021$4,150,000
-29.3%
264,529
-22.7%
0.01%
-28.6%
Q3 2021$5,866,000
-35.3%
342,243
-18.8%
0.01%
-36.4%
Q2 2021$9,065,000
+837.4%
421,422
+701.8%
0.01%
+450.0%
Q1 2019$967,000
-20.0%
52,559
-39.2%
0.00%
-50.0%
Q1 2017$1,209,00086,3890.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Profit Investment Management, LLC 326,997$1,412,6271.00%
Stonepine Capital Management, LLC 477,903$2,064,5410.69%
Krensavage Asset Management, LLC 360,429$1,5570.57%
Nantahala Capital Management 1,000,000$4,320,0000.37%
Monaco Asset Management SAM 135,000$583,2000.17%
CTC Alternative Strategies, Ltd. 18,400$79,4880.15%
GSA CAPITAL PARTNERS LLP 406,019$1,7540.15%
Sio Capital Management, LLC 97,616$421,7010.13%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$673,9200.13%
Virtus ETF Advisers LLC 48,530$209,6500.13%
View complete list of VANDA PHARMACEUTICALS INC shareholders